Article
Immunological hurdles to lung gene therapy
24 Mar 2003
Abstract excerpt
Gene delivery has the potential to offer effective treatment to patients with life-threatening lung diseases such as cystic fibrosis, alpha1-antitrypsin deficiency and lung cancer. Phase I/II clinical trials have shown that, in principle, gene transfer to the lung is feasible and safe. However, gene expression from both viral and non-viral gene delivery systems has been inefficient. In addition to extra- and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
